CHRS Coherus BioSciences, Inc.: institutional ownership and insider trading
157 funds reported holding $111M of Coherus BioSciences, Inc. in their latest 13F filings; in Q2 2026 funds net sold $1.83M, with 10 new positions and 20 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
Famous investors holding CHRS
- Two Sigma (Two Sigma Investments): $3.16M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $788K, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $245K, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $29.0K, 0.0% of the portfolio
Largest institutional holders of CHRS
- BlackRock, Inc. (BLK) — $16.8M
- Timothy G. Youngquist 2020 Irrevocable Trust — $15.8M
- VANGUARD GROUP INC — $14.2M
- VANGUARD CAPITAL MANAGEMENT LLC — $8.33M
- GEODE CAPITAL MANAGEMENT, LLC — $5.16M
- Samsara BioCapital, LLC — $4.80M
- Kohlberg Kravis Roberts & Co. L.P. — $4.18M
- STATE STREET CORP (STT, STT-PG) — $3.34M
- TWO SIGMA INVESTMENTS, LP — $3.16M
- CM Management, LLC — $2.94M
Recent CHRS insider trades
- May 23, 2025: Wahlstrom Mats sold 99,988 shares ($74.0K)
5%+ owners
- Timothy G. Youngquist 2020 Irrevocable Trust: 8.3% (Schedule 13G/A, filed May 15, 2026)
- BlackRock, Inc.: 5.8% (Schedule 13G, filed Jul 27, 2026)